Gujarat Kidney: No IPO Fund Deviation in Q2 FY27

Gujarat Kidney and Super Speciality Ltd has submitted its Statement of Deviation and Variation for the quarter ended September 30, 2026. The company confirms that there has been no deviation or variation in the utilization of IPO proceeds from the objects stated in the prospectus dated December 24, 2025. This statement was reviewed by the Audit Committee on November 4, 2026, and approved by shareholders via a special resolution on August 22, 2026. The funds were raised for the proposed acquisition of Parekh Hospital, part-payment for Ashwini Medical Centre, setting up a new hospital in Vadodara, buying robotics, and deploying dialysis machines.